Referral strategies for early diagnosis of axial spondyloarthritis

Nature Reviews Rheumatology

Volumn 8, Issue 5, 2012, Pages 262-268

  Rudwaleit, Martin ^a   Sieper, Joachim ^b  

^a Endokrinologikum Berlin   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; HLA B27 ANTIGEN; INFLIXIMAB;

ANKYLOSING SPONDYLITIS; BACKACHE; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG EFFICACY; EARLY DIAGNOSIS; HUMAN; MEDICAL EDUCATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; POPULATION RESEARCH; PREDICTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SPONDYLARTHRITIS; SYNDROME DELINEATION; TREATMENT PLANNING;

ADULT; AGE OF ONSET; AGED; BACK PAIN; BIOLOGICAL MARKERS; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; SACROILIAC JOINT; SEVERITY OF ILLNESS INDEX; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING;

EID: 84860572386     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2012.39     Document Type: Review

References (50)

1. Sieper, J., Braun, J., Rudwaleit, M., Boonen, A. & Zink, A. Ankylosing spondylitis: An overview. Ann. Rheum. Dis. 61 (Suppl. 3), iii8-iii18 (2002)
2. Braun, J. & Sieper, J. Ankylosing spondylitis. Lancet 369, 1379-1390 (2007)
3. van Der Linden, S. M., Valkenburg, H. A., De Jongh, B. M. & Cats, A. The risk of developing ankylosing spondylitis in HLA B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 27, 241-249 (1984)
4. Rudwaleit, M., Khan, M. A. & Sieper, J. The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum. 52, 1000-1008 (2005)
5. Underwood, M. R. & Dawes, P. Inflammatory back pain in primary care. Br. J. Rheumatol. 34, 1074-1077 (1995)
6. Chou, R. et al. Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann. Intern. Med. 147, 478-491 (2007)
7. Muche, B. et al. Anatomic structures involved in early and late-stage sacroiliitis in spondylarthritis: A detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum. 48, 1374-1384 (2003)
8. Rudwaleit, M. et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis-A consensual approach by the ASAS/OMERACT MRI Group. Ann. Rheum. Dis. 68, 1520-1527 (2009)
9. Rudwaleit, M., van Der Heijde, D., Khan, M. A., Braun, J. & Sieper, J. How to diagnose axial spondyloarthritis early. Ann. Rheum. Dis. 63, 535-543 (2004)
10. Rudwaleit, M., Feldtkeller, E. & Sieper, J. Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann. Rheum. Dis. 65, 1251-1252 (2006)
11. Rudwaleit, M. et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann. Rheum. Dis. 68, 770-776 (2009)
12. Rudwaleit, M. et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann. Rheum. Dis. 68, 777-783 (2009)
13. Poddubnyy, D. et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann. Rheum. Dis. 70, 1369-1374 (2011)
14. Sampaio-Barros, P. D. et al. Undifferentiated spondyloarthritis: A long-term follow-up. J. Rheumatol. 37, 1195-1199 (2010)
15. Bennett, A. N. et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum. 58, 3413-3418 (2008)
16. Mau, W. et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year follow-up. J. Rheumatol. 15, 1109-1114 (1988)
17. Oostveen, J. et al. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J. Rheumatol. 26, 1953-1958 (1999)
18. Rudwaleit, M. et al. The early disease stage in axial spondylarthritis: Results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 60, 717-727 (2009)
19. Poddubnyy, D. et al. Baseline radiographic damage, elevated acute phase reactants and cigarette smoking status predict radiographic progression in the spine in early axial spondyloarthritis. Arthritis Rheum. http://dx.doi.org/10. 1002/art.33465.
20. van Tubergen, A. et al. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: A longitudinal study. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2011-200411.
21. Braun, J. et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann. Rheum. Dis. 70, 896-904 (2011)
22. van Der Heijde, D. et al. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann. Rheum. Dis. 70, 905-908 (2011)
23. Haibel, H. et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum. 58, 1981-1991 (2008)
24. Barkham, N. et al. Clinical and imaging efficacy of infliximab in HLA B27 positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum. 60, 946-954 (2009)
25. Song, I. H. et al. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): A 48-week randomised controlled trial. Ann. Rheum. Dis. 70, 590-596 (2011)
26. Rudwaleit, M., Listing, J., Brandt, J., Braun, J. & Sieper, J. Prediction of a major clinical response (BASDAI 50) to TNF-Alpha blockers in ankylosing spondylitis. Ann. Rheum. Dis. 63, 665-670 (2004)
27. Rudwaleit, M. et al. Effectiveness, safety, and predictors of good clinical response in 1,250 patients treated with adalimumab for active ankylosing spondylitis. J. Rheumatol. 36, 801-808 (2009)
28. Vastesaeger, N. et al. Predicting the outcome of ankylosing spondylitis therapy. Ann. Rheum. Dis. 70, 973-981 (2011)
29. Bakland, G., Nossent, H. C. & Gran, J. T. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Care Res. 53, 850-855 (2005)
30. Gran, J. T., Husby, G. & Hordvik, M. Prevalence of ankylosing spondylitis in males and females in a young middle-Aged population of Tromsø, northern Norway. Ann. Rheum. Dis. 44, 359-367 (1985)
31. Liao, Z. T. et al. An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population. Scand. J. Rheumatol. 38, 455-459 (2009)
32. Braun, J. et al. Prevalence of spondylarthropathies in HLA B27 positive and negative blood donors. Arthritis Rheum. 41, 58-67 (1998)
33. Akkoc, N. & Khan, M. A. Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: Comment on the article by Braun, et al. Arthritis Rheum. 52, 4048-4049 (2005)
34. Gabriel, S. E. & Michaud, K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res. Ther. 11, 229 (2009)
35. Helmick, C. G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58, 15-25 (2008)
36. Adomaviciute, D. et al. Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania. Scand. J. Rheumatol. 37, 113-119 (2008)
37. Brandt, H. C. et al. Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis. Ann. Rheum. Dis. 66, 1479-1484 (2007)
38. Poddubnyy, D. et al. Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care. J. Rheumatol. 38, 2452-2460 (2011)
39. Feldtkeller, E., Khan, M. A., van Der Heijde, D., van Der Linden, S. & Braun, J. Age at disease onset and diagnosis delay in HLA B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol. Int. 23, 61-66 (2003)
40. Sieper, J. & Rudwaleit, M. Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann. Rheum. Dis. 64, 659-663 (2005)
41. Amor, B., Dougados, M. & Mijiyawa, M. Critères De classification des spondylarthropathies [French]. Rev. Rhum. 57, 85-89 (1990)
42. Calin, A. et al. Clinical history as a screening test for ankylosing spondylitis. JAMA 237, 2613-2614 (1977)
43. Rudwaleit, M., Metter, A., Listing, J., Sieper, J. & Braun, J. Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 54, 569-578 (2006)
44. Sieper, J. et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann. Rheum. Dis. 68, 784-788 (2009)
45. Hermann, J., Giessauf, H., Schaffler, G., Ofner, P. & Graninger, W. Early spondyloarthritis: Usefulness of clinical screening. Rheumatology (Oxford) 48, 812-816 (2009)
46. Braun, A., Saracbasi, E., Grifka, J., Schnitker, J. & Braun, J. Identifying patients with axial spondyloarthritis in primary care: How useful are items indicative of inflammatory back pain? Ann. Rheum. Dis. 70, 1782-1787 (2011)
47. Sieper, J. et al. Comparing 2 referral strategies to diagnose axial Spondyloarthritis: RADAR. Ann. Rheum. Dis. 70 (Suppl. 3), 81 (2011)
48. Jois, R. N., Macgregor, A. J. & Gaffney, K. Recognition of inflammatory back pain and ankylosing spondylitis in primary care. Rheumatology (Oxford) 47, 1364-1366 (2008)
49. Weisman, M. H. et al. Development and validation of a case ascertainment tool for ankylosing spondylitis. Arthritis Care Res. (Hoboken) 62, 19-27 (2010)
50. Schett, G. & Rudwaleit, M. Can we stop progression of ankylosing spondylitis? Best Pract. Res. Clin. Rheumatol. 24, 363-371 (2010)